ABSTRACT PURPOSE. To assess the ability of circulating tumor DNA (ctDNA)-based testing to identify patients with HER2 (encoded…
Five Prime Celebrates Many Firsts in Positive Phase II Cancer Trial Published: Nov.
Tada Images / Shutterstock Five Prime Therapeutics Inc., in collaboration Zai Lab Limited on the development bemarituzumab, a…
Enhertu Moves One Step Closer to Giving Gastric Cancer a Gut Punch Published: Oct 29, 2020 By Heather McKenzie BioSpace…
Antoine Yver, Executive Vice President and Global Head, Oncology Research and Development at Daiichi Sankyo, pictured above.
As summarized in Fig. 1, HER2-targeted strategies in gastric cancer consist of monoclonal antibodies (e.g., trastuzumab…